老虎证券

BIOCYTOGEN-B: CMBI Private Equity Series SPC Disposes of Shares, Long Position Falls to 8.81%

HK Disclosure
09/11

On September 8, 2026, CMBI Private Equity Series SPC sold 1.22 million shares of BIOCYTOGEN-B stock at an average of HKD 62.2724 per share, involving about HKD 76.03 million.

Prior to the disposal, CMBI Private Equity Series SPC's long position in BIOCYTOGEN-B was 10.98 million shares, representing 9.91%; following the disposal, the holding changed to 9.76 million shares, with the long position ratio falling to 8.81%.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10